文献速递睡眠呼吸障碍

托莫西汀联合奥昔布宁治疗阻塞性睡眠呼吸暂停:随机对照试验及病理生理学详细分析

Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiology
RSS 订阅 · Thorax

该随机对照试验评估托莫西汀联合奥昔布宁(AtoOxy)治疗阻塞性睡眠呼吸暂停(OSA)的效果。结果显示,与安慰剂相比,1个月AtoOxy治疗使呼吸暂停低通气指数(AHI)获得小而具有统计学意义的降低。反应最佳者见于唤醒阈值较高及肌肉效能较低、塌陷性较轻的参与者中,为靶向药物治疗提供了机制见解。

要点

  • 1个月AtoOxy治疗使OSA患者AHI较安慰剂显著降低。
  • 疗效在唤醒阈值较高的参与者中最佳,其次为肌肉效能较低者。
  • 生理内型分析有助于理解治疗机制并指导靶向药物开发。

核心结论

  • 1个月的AtoOxy治疗与安慰剂相比,产生了小而具有统计学显著性的AHI降低。
  • 反应异质性主要与唤醒阈值、肌肉效能和塌陷性等生理特质相关。

研究设计与样本

  • 随机对照试验,为迄今最大规模且包含详细生理学测量的研究。
  • 研究比较了1个月AtoOxy与安慰剂对OSA严重程度的影响并分析相关生理机制。

主要发现

  • AtoOxy使AHI较安慰剂出现小而显著的降低。
  • 反应最大见于唤醒阈值较高者,其次为肌肉效能较低及塌陷性较轻者。
  • 不同生理内型对药物治疗反应存在异质性。

关键数值与推荐

  • 原文未报告具体AHI降低数值、阈值或剂量信息。

临床怎么用

  • 生理内型分型可能有助于识别AtoOxy治疗的潜在应答者以提高疗效。
  • 该研究为OSA靶向药物治疗策略的开发和个体化选择提供了机制依据。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

WHAT IS ALREADY KNOWN ON THIS TOPIC Multi-night studies suggest that atomoxetine–oxybutynin (AtoOxy) can reduce obstructive sleep apnoea (OSA) severity and provide a promising new avenue for therapy; however, responses are heterogeneous and the physiological traits that determine treatment efficacy remain incompletely understood. WHAT THIS STUDY ADDS In the largest study to date with detailed physiological measurement, 1 month of AtoOxy produced a small but statistically significant reduction in the apnoea–hypopnoea index compared with placebo. Response was greatest in participants with a higher arousal threshold, and to a lesser extent in those with lower muscle effectiveness and milder collapsibility, providing new mechanistic insights. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY These findings highlight the value of physiological endotyping for understanding treatment mechanisms and guiding the development of targeted pharmacotherapy for OSA. Introduction Obstructive sleep apnoea (OSA) is a...

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Thorax:Atomoxetine plus oxybutynin for obstructive sleep apnoea: a randomised-controlled trial with detailed pathophysiology

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。